MAPT and Alzheimer disease: The demonstrated associations between elevated plasma NfL levels and various neuroimaging markers across the AD spectrum, along with its ability to predict future tau pathology, suggest that NfL holds significant promise for early detection, diagnosis, and monitoring of this debilitating condition.